Evidence map›Paper›PMID 26595526›Full record

ArticleOncotarget2016

ERK8 is a novel HuR kinase that regulates tumour suppressor PDCD4 through a miR-21 dependent mechanism.

Urszula Liwak-Muir, Christine C Dobson, Thet Naing, Quinlan Wylie, Lucia Chehade, Stephen D Baird, Pranesh K Chakraborty, Martin Holcik

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Posttranslational control of HuR function.Wiley interdisciplinary reviews. RNA · 2017
    Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Urszula Liwak-MuirMolecular Biomedicine Program, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.
Christine C DobsonMolecular Biomedicine Program, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.
Thet NaingMolecular Biomedicine Program, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.
Quinlan WylieMolecular Biomedicine Program, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.
Lucia ChehadeMolecular Biomedicine Program, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.
Stephen D BairdMolecular Biomedicine Program, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.
Pranesh K ChakrabortyDepartment of Pediatrics, University of Ottawa, Ottawa, ON, Canada.
Martin HolcikMolecular Biomedicine Program, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada.
Children's Hospital of Eastern Ontario · CAUniversity of Ottawa · CA

Funding

Canadian Institutes of Health Research FRN 74740Canadian Institutes of Health Research MOP 89737
6 · The paper itself

Abstract

Programmed cell death 4 (PDCD4) is a tumour suppressor implicated in cancer development and progression and was recently identified as a repressor of cap-independent translation of specific genes involved in the regulation of apoptosis. We show that the RNA-binding protein HuR binds to the PDCD4 3'UTR to protect it from miR-21-induced silencing. However, following H2O2 treatment, PDCD4 mRNA is degraded via miR-21 binding. Importantly, we identify HuR as a novel substrate of the ERK8 kinase pathway in response to H2O2 treatment. We show that phosphorylation of HuR by ERK8 prevents it from binding to PDCD4 mRNA and allows miR-21-mediated degradation of PDCD4.

Indexed as

3' Untranslated RegionsApoptosis Regulatory ProteinsBinding SitesELAV-Like Protein 1Enzyme ActivationExtracellular Signal-Regulated MAP KinasesFemaleGene Expression Regulation, NeoplasticGene SilencingHeLa CellsHumansHydrogen PeroxideMicroRNAsPhosphorylationRNA-Binding ProteinsRNA Interference3' Untranslated RegionsApoptosis Regulatory ProteinsELAVL1 protein, humanELAV-Like Protein 1Extracellular Signal-Regulated MAP KinasesHydrogen PeroxideMAPK15 protein, humanMicroRNAsMIRN21 microRNA, humanPDCD4 protein, humanRNA-Binding ProteinsRNA, MessengerkinasemiRNAtumour supressor

Identifiers

PMID26595526
PMCPMC4811471
OpenAlexW2174549091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.